Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralesional Glucantime vs Cryotherapy plus Intralesional Glucantime in Zoonotic Cutaneous Leishmaniasis
TCTR20171120004Completed
- Sponsor
- Office of Research & Technology, Qom University of Medical Sciences
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of meglumine antimoniate in cutaneous leishmaniasis (CL) (2 arms), sponsored by Office of Research & Technology, Qom University of Medical Sciences. Primary endpoint: Therapeutic efficacy. Started Mar 2014; status: completed.
02
Drugs
meglumine antimoniate
03
Conditions
cutaneous leishmaniasis (CL)
Beyond the preview
Go deeper on TCTR20171120004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20171120004.